Priothera
We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT).
1
Funding Rounds
$35.4m
Money raised
Overview
We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT).
- Website:
- Headquarters: Dublin
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Priothera has raised a total of $35.4m in funding over 1 rounds.
Key Insights:
- Priothera Series A round, October 2020: $35.4m
Priothera Series A round, October 2020
$35.4m
Industries
Priothera is active in the following industries: